Pathological assessment of discordant cases for molecular (BluePrint and MammaPrint) versus clinical subtypes for breast cancer among 621 patients from the EORTC 10041/BIG 3-04 (MINDACT) trial.
| Autor: | Viale, G., Slaets, L., de Snoo, F., van't, Veer L., Rutgers, E., Piccart, M., Bogaerts, J., den Akker, J. van, Stork-Sloots, L., Engelen, K., Russo, L., Dell'Orto, P., Cardoso, F. |
|---|---|
| Zdroj: | Cancer Research. Dec2012 Meeting Abstracts, Vol. 72 Issue 24a, p855-856. 2p. |
| Databáze: | Academic Search Ultimate |
| Externí odkaz: |
|